Reevaluating the Mutation Classification in Genetic Studies of Bradycardia Using ACMG/AMP Variant Classification Framework
Purpose. Next-generation sequencing (NGS) has become more accessible, leading to an increasing number of genetic studies of familial bradycardia being reported. However, most of the variants lack full evaluation. The relationship between genetic factors and bradycardia should be summarized and reeva...
Saved in:
| Main Authors: | Liting Cheng, Xiaoyan Li, Lin Zhao, Zefeng Wang, Junmeng Zhang, Zhuo Liang, Yongquan Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | International Journal of Genomics |
| Online Access: | http://dx.doi.org/10.1155/2020/2415850 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Updated ACMG/AMP specifications for variant interpretation and gene curations from the ClinGen RASopathy expert panels
by: Emma H. Wilcox, et al.
Published: (2025-01-01) -
38: Adoption of the ACMG and ClinGen copy number variant (CNV) technical standards in clinical genetic laboratories in the United States
by: Alexis Williams, et al.
Published: (2025-01-01) -
Genetic Approaches for the Treatment of Bradycardias
by: Demosthenes G Katritsis
Published: (2019-03-01) -
Identification of novel variants in carbamoyl phosphate synthetase 1 gene and comparative pathogenicity assessments of CPS1 missense variants following ACMG/AMP-ClinGen recommendation for computational tools
by: Fei Li, et al.
Published: (2025-06-01) -
P580: Comparing automated vs ACMG/AMP-based variant interpretation for the CDC Tier 1 conditions in a clinicogenomic cohort from US-based health systems
by: Kelly Schiabor Barrett, et al.
Published: (2025-01-01)